By combination of expression analysis, ROC curve analysis and survival analysis, MUC14 was identified as the most promising MUC member in breast cancer, with decreased expression in breast cancer, potential diagnostic biomarker and favorable prognostic predictor. This evidence concerns the gene EMCN and breast carcinoma.